Systemic Gene Silencing in Primary T Lymphocytes Using Targeted Lipid Nanoparticles-Reference-Cited by-同舟云学术

Systemic Gene Silencing in Primary T Lymphocytes Using Targeted Lipid Nanoparticles

Published:2015-06-10 Issue:7 Volume:9 Page:6706-6716
ISSN:1936-0851
Container-title:ACS Nano
language:en
Short-container-title:ACS Nano

Author:

Ramishetti Srinivas,Kedmi Ranit,Goldsmith Meir,Leonard Fransisca¹,Sprague Andrew G.²,Godin Biana¹,Gozin Michael,Cullis Pieter R.³,Dykxhoorn Derek M.⁴,Peer Dan

Affiliation:

1. Department of NanoMedicine, Houston Methodist Research Institute, Houston, Texas 77030, United States

2. Alnylam Pharmaceuticals, Cambridge, Massachusetts 02142, United States

3. Department of Biochemistry & Molecular Biology, Life Science Centre, University of British Columbia, Vancouver BC V6T 1Z4, Canada

4. Dr. John T Macdonald Foundation, Department of Human Genetics, Hussman Institute for Human Genomics, University of Miami, Miller School of Medicine, Miami, Florida 33136, United States

Funder

National Institute of Allergy and Infectious Diseases

European Research Council

Center for Nanoscience and Nanotechnology, Tel Aviv University

Planning and Budgeting Committee

Israel Science Foundation

Leona M. and Harry B. Helmsley Charitable Trust

Publisher

American Chemical Society (ACS)

Subject

General Physics and Astronomy,General Engineering,General Materials Science

Link